Cargando…
Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life....
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746083/ https://www.ncbi.nlm.nih.gov/pubmed/35012020 http://dx.doi.org/10.3390/jcm11010281 |
_version_ | 1784630499334946816 |
---|---|
author | Martínez-Ortega, Antonio Flores-Martinez, Álvaro Venegas-Moreno, Eva Dios, Elena Del Can, Diego Rivas, Eloy Kaen, Ariel Cárdenas Ruiz-Valdepeñas, Eugenio Fajardo, Elena Roldán, Florinda González-Rivera, Natividad Oliva, Rosario Fernández-Peña, José Ignacio Soto-Moreno, Alfonso Cano, David A. |
author_facet | Martínez-Ortega, Antonio Flores-Martinez, Álvaro Venegas-Moreno, Eva Dios, Elena Del Can, Diego Rivas, Eloy Kaen, Ariel Cárdenas Ruiz-Valdepeñas, Eugenio Fajardo, Elena Roldán, Florinda González-Rivera, Natividad Oliva, Rosario Fernández-Peña, José Ignacio Soto-Moreno, Alfonso Cano, David A. |
author_sort | Martínez-Ortega, Antonio |
collection | PubMed |
description | Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence. |
format | Online Article Text |
id | pubmed-8746083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87460832022-01-11 Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics Martínez-Ortega, Antonio Flores-Martinez, Álvaro Venegas-Moreno, Eva Dios, Elena Del Can, Diego Rivas, Eloy Kaen, Ariel Cárdenas Ruiz-Valdepeñas, Eugenio Fajardo, Elena Roldán, Florinda González-Rivera, Natividad Oliva, Rosario Fernández-Peña, José Ignacio Soto-Moreno, Alfonso Cano, David A. J Clin Med Article Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence. MDPI 2022-01-05 /pmc/articles/PMC8746083/ /pubmed/35012020 http://dx.doi.org/10.3390/jcm11010281 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martínez-Ortega, Antonio Flores-Martinez, Álvaro Venegas-Moreno, Eva Dios, Elena Del Can, Diego Rivas, Eloy Kaen, Ariel Cárdenas Ruiz-Valdepeñas, Eugenio Fajardo, Elena Roldán, Florinda González-Rivera, Natividad Oliva, Rosario Fernández-Peña, José Ignacio Soto-Moreno, Alfonso Cano, David A. Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title | Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title_full | Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title_fullStr | Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title_full_unstemmed | Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title_short | Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics |
title_sort | sex hormone receptor expression in craniopharyngiomas and association with tumor aggressiveness characteristics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746083/ https://www.ncbi.nlm.nih.gov/pubmed/35012020 http://dx.doi.org/10.3390/jcm11010281 |
work_keys_str_mv | AT martinezortegaantonio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT floresmartinezalvaro sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT venegasmorenoeva sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT dioselena sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT delcandiego sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT rivaseloy sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT kaenariel sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT cardenasruizvaldepenaseugenio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT fajardoelena sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT roldanflorinda sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT gonzalezriveranatividad sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT olivarosario sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT fernandezpenajoseignacio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT sotomorenoalfonso sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics AT canodavida sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics |